The Helicobacter pylori cag pathogenicity island protein CagN is a bacterial membrane-associated protein that is processed at its C terminus.

Infection and Immunity
Kevin M BourzacKaren Guillemin

Abstract

Helicobacter pylori infects nearly half the world's population and is associated with a spectrum of gastric maladies. Infections with cytotoxin-associated gene pathogenicity island (cag PAI)-containing strains are associated with an increased risk for gastric cancer. The cag PAI contains genes encoding a type IV secretion system (T4SS) and a delivered effector, CagA, that becomes tyrosine phosphorylated upon delivery into host cells and initiates changes in cell signaling. Although some cag PAI genes have been shown to be required for CagA delivery, a subset of which are homologues of T4SS genes from Agrobacterium tumefaciens, the majority have no known function or homologues. We have performed a detailed investigation of one such cag PAI protein, CagN, which is encoded by the gene HP0538. Our results show that CagN is not delivered into host cells and instead is associated with the bacterial membrane. We demonstrate that CagN is cleaved at its C terminus by a mechanism that is independent of other cag PAI proteins. Finally, we show that a delta cagN mutant is not impaired in its ability to deliver CagA to gastric epithelial cells and initiate cell elongation.

References

Dec 10, 1996·Proceedings of the National Academy of Sciences of the United States of America·S CensiniA Covacci
Feb 3, 2000·Proceedings of the National Academy of Sciences of the United States of America·M SteinA Covacci
Feb 24, 2000·The Journal of Experimental Medicine·A Covacci, R Rappuoli
Jun 27, 2000·Journal of Bacteriology·L C SmeetsJ G Kusters
Dec 20, 2000·Proceedings of the National Academy of Sciences of the United States of America·N SalamaS Falkow
Jan 15, 2002·The Journal of Biological Chemistry·Matthias SelbachSteffen Backert
Jun 18, 2002·Infection and Immunity·Dirk BumannPeter R Jungblut
Nov 2, 2002·Proceedings of the National Academy of Sciences of the United States of America·Karen GuilleminStanley Falkow
Jun 5, 2003·Cellular Microbiology·Jiro TanakaChihiro Sasakawa
Jun 20, 2003·Microbes and Infection·Jani L O'Rourke, Adrian Lee
Jun 26, 2003·Molecular Microbiology·Manfred RohdeRainer Haas
Jul 19, 2003·International Journal of Medical Microbiology : IJMM·Renate BuhrdorfWolfgang Fischer
Jan 13, 2004·Proceedings of the National Academy of Sciences of the United States of America·Zhao-Qing Luo, Ralph R Isberg
Feb 3, 2004·The Journal of Clinical Investigation·Martin J Blaser, John C Atherton
Mar 24, 2004·Nature Reviews. Microbiology·Eric Cascales, Peter J Christie
May 25, 2004·Infection and Immunity·Yasser Musa IbrahimTim J Mitchell
Jun 30, 2004·Journal of Molecular Biology·Jannick Dyrløv BendtsenSøren Brunak
Sep 17, 2004·Nature Reviews. Microbiology·Denise M MonackStanley Falkow
Oct 19, 2004·Nature Immunology·Jérôme VialaRichard L Ferrero
Nov 18, 2004·Journal of Bacteriology·Nina R SalamaStanley Falkow
Jan 12, 2005·Proceedings of the National Academy of Sciences of the United States of America·Ralf SchuleinChristoph Dehio
Jan 13, 2005·Proceedings of the National Academy of Sciences of the United States of America·Annette C VergunstPaul J J Hooykaas
Jun 15, 2005·Cellular Microbiology·Kevin M Bourzac, Karen Guillemin
Jun 24, 2005·Proceedings of the National Academy of Sciences of the United States of America·Sabine BrandtSteffen Backert
Oct 12, 2005·PLoS Genetics·Helga GressmannMark Achtman

❮ Previous
Next ❯

Citations

Nov 24, 2011·Current Microbiology·Hua WangShihe Shao
Nov 15, 2006·Infection and Immunity·David N BaldwinNina R Salama
Jan 23, 2009·Journal of Clinical Microbiology·Kathleen R JonesJeong-Heon Cha
May 5, 2017·The FEBS Journal·Enrique MerinoGermán Rubén Aguilar-Gutiérrez
May 11, 2018·Microbiology and Molecular Biology Reviews : MMBR·Skander HathroubiKaren M Ottemann

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.